Effect of the Tyrosine Kinase Inhibitors (Sunitinib, Sorafenib, Dasatinib, and Imatinib) on Blood Glucose Levels in Diabetic and Non-diabetic Patients in General Clinical Practice (Poster)

Authors

Nicole M. Agostino DO, Lehigh Valley Health NetworkFollow
Vernon M. Chinchilli PhD, Lehigh Valley Health Network
Christopher J. Lynch PhD, Lehigh Valley Health Network
Anita M. Koszyk-Szewczyk MD, Lehigh Valley Health Network
Rebecca Gingrich RN, MS, OCN, Lehigh Valley Health Network
Jeffery Sivik D Pharma, Lehigh Valley Health Network
Joseph J. Darbick MD, FACP, Lehigh Valley Health Network

Publication/Presentation Date

2010

Comments

Copyright © Lehigh Valley Health Network

Published In/Presented At

Agostino N, Chinchilli V, Drabick J, et al. Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice. Poster presentation.

Disciplines

Analytical, Diagnostic and Therapeutic Techniques and Equipment | Chemicals and Drugs | Medical Sciences | Medicine and Health Sciences | Therapeutics

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Department of Medicine Faculty

Document Type

Poster